| Literature DB >> 35399988 |
Harold G Moore1, Christopher A Schneble2, Joseph B Kahan2, Jonathan N Grauer2, Lee E Rubin2.
Abstract
Background: Unicompartmental knee arthroplasty (UKA) may be considered for select patients to relieve pain and restore function of the knee joint. Little research to date has explored the complication profile of UKA in an older population. The current study uses a large national surgical database to examine the 30-day postoperative adverse events in octogenarians compared with those in nonoctogenarians. Material and methods: The 2012-2018 National Surgical Quality Improvement Program database was queried for all patients undergoing UKA for osteoarthritis. Those patients aged 80 years or older composed the octogenarian age group. Demographics and medical comorbidities were cataloged, in addition to 30-day adverse events. Multivariate regression analysis controlled for differences in demographics and comorbidities. Significance was set at P < .05.Entities:
Keywords: Complications; NSQIP; Octogenarian; UKA; Unicompartmental knee arthroplasty
Year: 2022 PMID: 35399988 PMCID: PMC8991237 DOI: 10.1016/j.artd.2022.02.009
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Figure 1Distribution of patient ages in receiving unicompartmental knee arthroplasty (UKA) NSQIP 2012-2018.
Demographic and comorbidities of patients in different age groups undergoing UKA for osteoarthritis in the NSQIP Database between 2012 and 2018.
| Total | Age groups | ||||
|---|---|---|---|---|---|
| <80 | ≥80 | ||||
| N = 9375 | N = 728 | ||||
| Age (y) | 62.8 ± 9.1 | 83.4 ± 2.9 | |||
| Sex | .475 | ||||
| Male | 4623 | 49.3% | 369 | 50.7% | |
| Female | 4752 | 50.7% | 359 | 49.3% | |
| BMI | |||||
| 18-25 | 992 | 10.6% | 190 | 26.1% | |
| 25-30 | 2945 | 31.4% | 326 | 44.8% | |
| 30-35 | 2947 | 31.4% | 160 | 21.98% | |
| >35 | 2491 | 26.6% | 52 | 7.14% | |
| Functional status | |||||
| Independent | 9312 | 99.3% | 707 | 97.1% | |
| Dependent | 63 | 0.7% | 21 | 2.9% | |
| ASA | |||||
| 1-2 | 5832 | 62.2% | 285 | 39.2% | |
| 3 | 3462 | 36.9% | 424 | 58.2% | |
| >4 | 81 | 0.9% | 19 | 2.6% | |
| Diabetes mellitus | .590 | ||||
| Non-insulin-dependent | 1070 | 11.4% | 92 | 12.6% | |
| Insulin-dependent | 374 | 4.0% | 30 | 3.1% | |
| Smoker | 929 | 9.9% | 13 | 1.8% | |
| CHF | 14 | 0.2% | 4 | 0.6% | |
| COPD | 252 | 2.7% | 43 | 5.9% | |
| Hypertension | 5112 | 54.5% | 561 | 77.1% | |
| Chronic corticosteroid use | 162 | 1.7% | 17 | 2.3% | .232 |
| Bleeding disorder | 149 | 1.6% | 23 | 3.2% | |
| Anesthesia type (general) | 4187 | 44.7% | 297 | 40.8% | |
| Prolonged operative time (≥120 min) | 1169 | 12.5% | 60 | 8.2% | |
| Procedure performed outpatient | 3403 | 36.3% | 275 | 37.8% | .425 |
BMI, Body Mass Index.
Significance was set at P < .05 and indicated by bold font.
Figure 2Rate of any adverse event within the 30-day postoperative period by age group for patients undergoing UKA in NSQIP between 2012-2018.
Rate of serious and minor adverse events and statistical comparisons using univariate chi-squared comparisons and multivariate logistic regression odds ratios.
| Total | Age < 80 y | Age ≥ 80 y | OR | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|
| N = 9375 | N = 728 | |||||||
| Any adverse event | 263 | 2.8% | 34 | 4.7% | .004 | 1.46 | 0.98-2.14 | .057 |
| Serious adverse event | 166 | 1.8% | 18 | 2.5% | .172 | 1.07 | 0.64-1.81 | .785 |
| Wound complication | 79 | 0.8% | 6 | 0.8% | .958 | 0.82 | 0.35-1.96 | .661 |
| Cardiac event | 9 | 0.1% | 4 | 0.6% | 2.60 | 0.65-10.3 | .175 | |
| Pneumonia | 14 | 0.2% | 3 | 0.4% | .096 | 1.41 | 0.35-5.63 | .627 |
| Renal complications | 3 | 0.02% | 0 | 0.0% | - | - | - | - |
| Stroke | 2 | 0.01% | 0 | 0.0% | - | - | - | - |
| DVT/PE | 52 | 0.6% | 2 | 0.3% | .318 | 0.44 | 0.11-1.91 | .278 |
| Sepsis or septic shock | 10 | 0.11% | 4 | 0.55% | 3.36 | 0.86-13.2 | .083 | |
| Death | 0.05% | 3 | 0.41% | 6.12 | 1.27-29.48 | |||
| Minor adverse event | 59 | 0.6% | 14 | 1.9% | 2.97 | 1.55-5.68 | ||
| Blood transfusion | 23 | 0.3% | 7 | 1.0% | 3.42 | 1.32-8.86 | ||
| Urinary tract infection | 37 | 0.4% | 8 | 1.1% | 2.98 | 1.29-6.92 | ||
| Return to operation room | 85 | 0.9% | 7 | 1.0% | .881 | 0.97 | 0.43-2.21 | .954 |
| Prolonged LOS (>3 d) | 433 | 4.6% | 60 | 8.2% | 2.30 | 1.67-3.14 | ||
| Non-home discharge | 403 | 4.3% | 123 | 16.9% | 4.50 | 3.51-5.76 | ||
| Readmission | 176 | 2.3% | 29 | 4.8% | 1.72 | 1.11-2.66 | ||
BMI, Body Mass Index; DVT, deep vein thrombosis; PE, pulmonary embolism.
Regression analysis adjusted for ASA class, BMI, functional status, tobacco use, use of general anesthesia, CHF, COPD, bleeding disorder, and prolonged operative time with the nonoctogenarian population used as the reference cohort. Significance was set at P < .05 and indicated by bold font. Empty cells indicate one or more comparisons had less than 10 patients.
Home discharge was considered home or to a facility which was considered home at the time of admission.
Figure 3Forest plot of multivariate odds of perioperative adverse events within the 30-day postoperative period. Darkened error bars indicate statistical significance (P < .05).